Derived neutrophil-to-lymphocyte ratio as a predictor of no-reflow in ST-elevation myocardial infarction

dNLR is a simple, cost-effective marker that may help identify patients at high risk of no-reflow in STEMI. Further prospective studies are warranted.

Authors

Institutions

Publication Details

Journal
Biomarkers in Medicine
Published
2025-11-02
DOI
https://doi.org/10.1080/17520363.2025.2590790
Citations
5
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
5.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Derived neutrophil-to-lymphocyte ratio as a predictor of no-reflow in ST-elevation myocardial infarction

Alperen Taş, Çağatay Tunca, Muhammet Salih Ateş
5 citations
Biomarkers in Medicine
Inflammatory Biomarkers in Disease Prognosis
5.23
article

Derived neutrophil-to-lymphocyte ratio as a predictor of no-reflow in ST-elevation myocardial infarction

Alperen Taş, Çağatay Tunca, Muhammet Salih Ateş
article en
5 citations

Abstract

dNLR is a simple, cost-effective marker that may help identify patients at high risk of no-reflow in STEMI. Further prospective studies are warranted.

Biomarkers in MedicineVol. 19(21)
Ahi Evran University (TR), Memorial Ankara Hospital (TR)
Openalex Percentile: Top 4%
Inflammatory Biomarkers in Disease Prognosis
5.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.